Published on : Dec 13, 2017
Albany, New York, December 13, 2017: The global downstream processing market is likely to witness steady growth during the forecast period 2017-2022 on account of a host of factors on which a new research report offers holistic insights. The report titled “Downstream Processing Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2022)” offers analysis and insights that are likely to impact the market during the forecast period. The report has been added to the comprehensive repository of Market Research Hub (MRH).
Downstream processing is used in a variety of manufacturing processes including the manufacture of antibiotics, insulin, vaccines, etc. Growth of the biopharmaceuticals industry has been one of the major contributors to the growth of the downstream processing market, as it has led to an increase in demand for the process at various stages. Growth of infectious diseases and revamp of healthcare facilities in many emerging countries has also provided an impetus to the growth of the market during the forecast period. On the back of these factors, the global downstream processing market is likely to reach a value of nearly US$ 26 Bn by the end of 2022.
North America is likely to be the leading market for downstream processing globally. The market in North America will be led by the US, with Canada accounting for minor revenue share. The strong biopharmaceutical industry in North America, combined with growing demand for recycling products to reduce environmental waste is likely to crate growth opportunities for the downstream processing market.
By product type, chromatography columns and resins segment is likely to remain lucrative. According to the report, this segment is likely to surpass a revenue of US$ 10 Bn by the end of 2022. This segment currently accounts for nearly one-third revenue share of the market.
Biopharmaceutical manufacturers remain one of the leading end-users of downstream processing, and the trend is likely to continue during the forecast period as well. This segment is likely to reach a value of nearly US$ 15.70 Bn by the end of 2022. Biopharmaceutical manufacturers segment is also likely to account for two-third revenue share of the market. Some of the leading players profiled in the report include 3M Company, Thermo Fisher Scientific, Inc., Danaher Corporation, General Electric Company, Repligen Corporation, Merck & Co Inc., Sartorius Aktiengesellschaft, Lonza Group Ltd. Eppendorf AG, and Corning Incorporated.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1392900
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org